Pfizer’s Covid vaccine could quickly be out there in India as the method of its approval is within the “final stages”, the US pharmaceutical large has stated.
“Pfizer is now in the final stages to get approval for COVID-19 vaccine in India. I hope very soon we will finalise an agreement with the government,” firm CEO Albert Bourla stated yesterday whereas talking at a digital occasion, the fifteenth Annual BioPharma and Healthcare Summit.
The vaccine was developed in partnership with the German agency BioNtech. It has a really excessive efficacy of over 90 per cent in stopping Covid, ANI reported.
Earlier this month, NITI Aayog member Dr VK Paul had additionally stated that the approval to the vaccines of Pfizer and Moderna was into account in India.
Recently, the Drugs Controller General of India (DCGI) did away with particular trials of COVID-19 vaccines authorised by different worldwide regulatory our bodies — a giant transfer that’s prone to clear the way in which for international vaccines like Pfizer’s and Moderna’s for the nation’s pressing requirement.
In a letter, DCGI Chief VG Somani had stated this might be relevant for vaccines authorised for restricted use by the US Food and Drug Administration, European Medicines Agency, the UK’s Medicines and Healthcare Products Regulatory Agency, and Japan’s Pharmaceuticals and Medical Devices Agency, in addition to these listed for emergency use by the World Health Organisation.
Only three vaccines — Bharat Biotech’s Covaxin, AstraZeneca’s Covishield (manufactured by Serum Institute of India), and the Russian-made Sputnik V — are in use in India presently.